IP Library Granted Patent US 7,846,681
Granted Patent B2
US 7,846,681 · App. 12/426,479 · Granted Dec 7, 2010

Apoptosis modulator BCL-B and methods for making and using same

Assignee: Sanford-Burnham Medical Research Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,846,681
App. No.
12/426,479
Granted
Dec 7, 2010
Kind
B2
Abstract

A novel human member of the Bcl-2 family Bcl-B has been identified, which is closest in amino-acid sequence homology to the Boo (Diva) protein. The Bcl-B protein is widely expressed in adult human tissues. The Bcl-B protein modulates apoptosis. Bcl-B also binds Bcl-2. BCl-XL, and Bax but not Bak. Bcl-B displays a unique pattern of selectivity for binding and regulating the function of other members of the Bcl-2 family. Accordingly, provided herein is a method for identifying a molecule that binds to the Bcl-B polypeptide, by contacting the Bcl-B polypeptide with a test molecule and determining whether the test molecule binds to the polypeptide.

Claims (14)

1. A method for identifying a molecule that binds to a polypeptide having at least about 99% identity to SEQ ID NO:2, said method comprising contacting the polypeptide with a test molecule and determining whether the test molecule binds to the polypeptide.

2. The method of claim 1 , wherein the polypeptide contains one or more 15N-labeled amino acids, and the binding is detected by resonance changes in the polypeptide.

3. The method of claim 1 , wherein the test molecule comprises a polypeptide sequence.

4. The method of claim 1 , wherein the polypeptide sequence comprises an antibody.

5. The method of claim 1 , wherein the test molecule is attached to the surface of a substrate.

6. The method of claim 1 , wherein the test molecule is in a library of molecules.

7. The method of claim 6 , wherein the library is attached at discrete positions of a substrate.

8. The method of claim 1 , wherein the contacting is in solution.

9. The method of claim 1 , wherein the polypeptide has the sequence of SEQ ID NO:2.

10. The method of claim 1 , wherein the polypeptide consists of the sequence of SEQ ID NO:2.

11. The method of claim 1 , wherein the polypeptide is attached to the surface of a substrate.

12. The method of claim 1 , wherein the contacting is in solid phase.

13. The method of claim 1 , wherein the contacting is in a cell.

14. The method of claim 1 , wherein the contacting is in situ.

Assignments (3)
CONFIRMATORY LICENSE Recorded Nov 13, 2019
From: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 050997/0548 →
CHANGE OF NAME Recorded Sep 29, 2010
From: THE BURNHAM INSTITUTE
To: BURNHAM INSTITUTE FOR MEDICAL RESEARCH
Reel/Frame 025064/0853 →
CHANGE OF NAME Recorded Sep 29, 2010
From: BURNHAM INSTITUTE FOR MEDICAL RESEARCH
To: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
Reel/Frame 025064/0867 →
Continuity (3)
Division 1007117400 · Feb 7, 2002
Provisional Application 6026716600 · Feb 7, 2001
Related Publication 20090305904A1 · Dec 10, 2009